Skip to the page

Data / Drug companies / Orphenadrine citrate

Orphenadrine citrate: 18 companies and 20 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Orphenadrine citrate is listed in the FDA National Drug Code Directory by 18 companies, with 20 products in commercial distribution. 20 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; injection; injection, solution, and the newest product started marketing on October 15, 2025.

The request: Get every company that lists orphenadrine citrate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
18
Products
20
Generic (ANDA) products
20 (100.0%)
Application numbers
5
Routes
Oral, Intramuscular, Intravenous
openFDA record search
api.fda.gov

Companies that list orphenadrine citrate

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Advanced Rx of Tennessee, LLC2tablet, extended releaseGeneric drugs (ANDA)May 23, 2023
Proficient Rx LP2tablet, extended releaseGeneric drugs (ANDA)February 15, 2000
A-S Medication Solutions1tablet, extended releaseGeneric drugs (ANDA)June 19, 1998
Actavis Pharma, Inc.1injectionGeneric drugs (ANDA)July 8, 2010
Bryant Ranch Prepack1tablet, extended releaseGeneric drugs (ANDA)June 19, 1998
Bryant Ranch Prepack1tablet, extended releaseGeneric drugs (ANDA)June 19, 1998
Hikma Pharmaceuticals USA Inc.1injectionGeneric drugs (ANDA)April 28, 2003
Lupin Pharmaceuticals,Inc.1tablet, extended releaseGeneric drugs (ANDA)June 19, 1998
Northwind Health Company, LLC1tablet, extended releaseGeneric drugs (ANDA)January 30, 2024
NuCare Pharmaceuticals, Inc.1tablet, extended releaseGeneric drugs (ANDA)June 19, 1998
PD-Rx Pharmaceuticals, Inc.1tablet, extended releaseGeneric drugs (ANDA)June 19, 1998
Preferred Pharmaceuticals Inc.1tablet, extended releaseGeneric drugs (ANDA)June 19, 1998
Quality Care Products LLC1tablet, extended releaseGeneric drugs (ANDA)February 7, 2011
Redpharm Drug1tablet, extended releaseGeneric drugs (ANDA)February 15, 2000
Remedyrepack Inc.1tablet, extended releaseGeneric drugs (ANDA)October 15, 2025
Sagent Pharmaceuticals1injection, solutionGeneric drugs (ANDA)October 1, 2011
Sandoz Inc1tablet, extended releaseGeneric drugs (ANDA)February 15, 2000
St. Mary's Medical Park Pharmacy1tablet, extended releaseGeneric drugs (ANDA)October 1, 2006

Dosage forms

Dosage formProductsShare
Tablet, extended release1785%
Injection210%
Injection, solution15%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)20100%

Pharmacologic classes

ClassProducts
Muscle Relaxant20

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.